SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

Takanori Kitamura1, Kohei Kometani, Hiroki Hashida

  • 1Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Nature Genetics
|March 21, 2007
PubMed

Insights

Loss of TGF-beta signaling in colorectal cancer recruits immature myeloid cells (iMCs) that promote invasion. Blocking CCR1 signaling prevents iMC accumulation and suppresses tumor spread.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial in tumor suppression.
  • Inactivation of TGF-beta signaling is linked to colorectal cancer progression.

Purpose of the Study:

  • To investigate the role of immature myeloid cells (iMCs) in colorectal tumor invasion.
  • To elucidate the mechanism by which TGF-beta pathway inactivation promotes tumor spread.

Main Methods:

  • Utilized cis-Apc(+/Delta716) Smad4(+/-) mutant mice, a model for invasive colorectal cancer with blocked TGF-beta signaling.
  • Analyzed the recruitment and characteristics of iMCs at the tumor invasion front.
  • Investigated the role of CC-chemokine receptor 1 (CCR1) and its ligand CCL9 in iMC migration and tumor invasion using gene deletion models.

Main Results:

  • Identified a novel population of CD34(+) iMCs recruited from bone marrow to the tumor invasion front.
  • These iMCs express matrix metalloproteinases (MMP9, MMP2) and CCR1, migrating towards CCL9.
  • CCL9 expression was elevated in tumor epithelium of adenocarcinomas.
  • Deleting Ccr1 abolished iMC accumulation and significantly suppressed tumor invasion.

Conclusions:

  • Loss of TGF-beta signaling in colorectal tumors drives the recruitment of iMCs.
  • The CCR1-CCL9 axis mediates iMC accumulation and promotes tumor invasion.
  • Targeting iMC recruitment via CCR1 inhibition represents a potential therapeutic strategy for colorectal cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...